Evidence map›Paper›PMID 35581241›Full record

ArticleScientific reports2022

Inactivation of SARS-CoV-2 by a chitosan/α-Ag

Paula Fabiana Santos Pereira, Ana Carolina Alves de Paula E Silva, Bruna Natália Alves da Silva Pimentel, Ivo Mateus Pinatti, Alexandre Zirpoli Simões, Carlos Eduardo Vergani, Débora Ferreira Barreto-Vieira, Marcos Alexandre Nunes da Silva, Milene Dias Miranda, Maria Eduarda Santos Monteiro and 5 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.4field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 19 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 4 institutions in 3 countries.

Paula Fabiana Santos PereiraCDMF, LIEC, Department of Chemistry, Federal University of São Carlos (UFSCar), P.O. Box 676, São Carlos, SP, 13565-905, Brazil.
Ana Carolina Alves de Paula E SilvaDepartment of Dental Materials and Prosthodontics, School of Dentistry, São Paulo State University (UNESP), 1680 Humaitá Street, Araraquara, SP, 14801-903, Brazil.
Bruna Natália Alves da Silva PimentelDepartment of Dental Materials and Prosthodontics, School of Dentistry, São Paulo State University (UNESP), 1680 Humaitá Street, Araraquara, SP, 14801-903, Brazil.
Ivo Mateus PinattiDepartment of Physical and Analytical Chemistry, University Jaume I (UJI), 12071, Castelló, Spain.
Alexandre Zirpoli SimõesFaculty of Engineering of Guaratinguetá, São Paulo State University (UNESP), Guaratinguetá, SP, 12516-410, Brazil.
Carlos Eduardo VerganiDepartment of Dental Materials and Prosthodontics, School of Dentistry, São Paulo State University (UNESP), 1680 Humaitá Street, Araraquara, SP, 14801-903, Brazil.
Débora Ferreira Barreto-VieiraLaboratory of Viral Morphology and Morphogenesis, Oswaldo Cruz Institute, Fiocruz, Avenida Brasil, Rio de Janeiro, Brazil.
Marcos Alexandre Nunes da SilvaLaboratory of Viral Morphology and Morphogenesis, Oswaldo Cruz Institute, Fiocruz, Avenida Brasil, Rio de Janeiro, Brazil.
Milene Dias MirandaLaboratory of Respiratory Viruses and Measles, Oswaldo Cruz Institute, Fiocruz, Avenida Brasil, Rio de Janeiro, Brazil.
Maria Eduarda Santos MonteiroLaboratory of Respiratory Viruses and Measles, Oswaldo Cruz Institute, Fiocruz, Avenida Brasil, Rio de Janeiro, Brazil.
Amanda TucciLaboratory of Respiratory Viruses and Measles, Oswaldo Cruz Institute, Fiocruz, Avenida Brasil, Rio de Janeiro, Brazil.
Carlos Doñate-BuendíaGROC UJI, Institute of New Imaging Technologies, Universitat Jaume I, Avda. Sos Baynat sn, 12071, Castellón de la Plana, Spain.ORCID 0000-0002-7022-0960
Gladys Mínguez-VegaGROC UJI, Institute of New Imaging Technologies, Universitat Jaume I, Avda. Sos Baynat sn, 12071, Castellón de la Plana, Spain.
Juan AndrésDepartment of Physical and Analytical Chemistry, University Jaume I (UJI), 12071, Castelló, Spain.
Elson LongoCDMF, LIEC, Department of Chemistry, Federal University of São Carlos (UFSCar), P.O. Box 676, São Carlos, SP, 13565-905, Brazil. elson.liec@gmail.com.
Fundação Oswaldo Cruz · BRUniversitat Jaume I · ESUniversidade Estadual Paulista (Unesp) · BRUniversidade Federal de São Carlos · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In the current COVID-19 pandemic, the next generation of innovative materials with enhanced anti-SARS-CoV-2 activity is urgently needed to prevent the spread of this virus within the community. Herein, we report the synthesis of chitosan/α-Ag

Indexed as

ChitosanCOVID-19Escherichia coli InfectionsStaphylococcal InfectionsAnti-Bacterial AgentsCandida albicansEscherichia coliHumansLasersMicrobial Sensitivity TestsPandemicsSARS-CoV-2Staphylococcus aureusAnti-Bacterial AgentsChitosan

Identifiers

PMID35581241
PMCPMC9114143
OpenAlexW4280494846

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.